MovDisordV3, Main, Exploration, bibRecord, 000155

NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.

Identifieur interne : 000155 ( Main/Exploration ); précédent : 000154; suivant : 000156

NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.

Auteurs : Christopher F. O'Brien [États-Unis] ; Roland Jimenez [États-Unis] ; Robert A. Hauser [États-Unis] ; Stewart A. Factor [États-Unis] ; Joshua Burke [États-Unis] ; Daniel Mandri [États-Unis] ; Julio C. Castro-Gayol [États-Unis]

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2015.

RBID : pubmed:26346941

Abstract

Tardive dyskinesia is a persistent movement disorder induced by chronic neuroleptic exposure. NBI-98854 is a novel, highly selective, vesicular monoamine transporter 2 inhibitor. We present results of a randomized, 6-week, double-blind, placebo-controlled, dose-titration study evaluating the safety, tolerability, and efficacy of NBI-98854 for the treatment of tardive dyskinesia.

DOI: 10.1002/mds.26330
PubMed: 26346941

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.</title>
<author><name sortKey="O Brien, Christopher F" sort="O Brien, Christopher F" uniqKey="O Brien C" first="Christopher F" last="O'Brien">Christopher F. O'Brien</name>
<affiliation wicri:level="2"><nlm:affiliation>Neurocrine Biosciences, San Diego, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurocrine Biosciences, San Diego, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jimenez, Roland" sort="Jimenez, Roland" uniqKey="Jimenez R" first="Roland" last="Jimenez">Roland Jimenez</name>
<affiliation wicri:level="2"><nlm:affiliation>Neurocrine Biosciences, San Diego, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurocrine Biosciences, San Diego, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A" last="Hauser">Robert A. Hauser</name>
<affiliation wicri:level="4"><nlm:affiliation>University of South Florida, Tampa, Florida, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Factor, Stewart A" sort="Factor, Stewart A" uniqKey="Factor S" first="Stewart A" last="Factor">Stewart A. Factor</name>
<affiliation wicri:level="2"><nlm:affiliation>Emory University, Atlanta, Georgia, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Emory University, Atlanta, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Burke, Joshua" sort="Burke, Joshua" uniqKey="Burke J" first="Joshua" last="Burke">Joshua Burke</name>
<affiliation wicri:level="2"><nlm:affiliation>Neurocrine Biosciences, San Diego, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurocrine Biosciences, San Diego, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mandri, Daniel" sort="Mandri, Daniel" uniqKey="Mandri D" first="Daniel" last="Mandri">Daniel Mandri</name>
<affiliation wicri:level="2"><nlm:affiliation>Biscayne Bay Institute, Miami, Florida, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Biscayne Bay Institute, Miami, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Castro Gayol, Julio C" sort="Castro Gayol, Julio C" uniqKey="Castro Gayol J" first="Julio C" last="Castro-Gayol">Julio C. Castro-Gayol</name>
<affiliation wicri:level="2"><nlm:affiliation>Research in Miami, Miami, Florida, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Research in Miami, Miami, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26346941</idno>
<idno type="pmid">26346941</idno>
<idno type="doi">10.1002/mds.26330</idno>
<idno type="wicri:Area/PubMed/Corpus">000044</idno>
<idno type="wicri:Area/PubMed/Curation">000044</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000155</idno>
<idno type="wicri:Area/Ncbi/Merge">004474</idno>
<idno type="wicri:Area/Ncbi/Curation">004474</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004474</idno>
<idno type="wicri:Area/Main/Merge">000155</idno>
<idno type="wicri:Area/Main/Curation">000155</idno>
<idno type="wicri:Area/Main/Exploration">000155</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.</title>
<author><name sortKey="O Brien, Christopher F" sort="O Brien, Christopher F" uniqKey="O Brien C" first="Christopher F" last="O'Brien">Christopher F. O'Brien</name>
<affiliation wicri:level="2"><nlm:affiliation>Neurocrine Biosciences, San Diego, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurocrine Biosciences, San Diego, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jimenez, Roland" sort="Jimenez, Roland" uniqKey="Jimenez R" first="Roland" last="Jimenez">Roland Jimenez</name>
<affiliation wicri:level="2"><nlm:affiliation>Neurocrine Biosciences, San Diego, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurocrine Biosciences, San Diego, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A" last="Hauser">Robert A. Hauser</name>
<affiliation wicri:level="4"><nlm:affiliation>University of South Florida, Tampa, Florida, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Factor, Stewart A" sort="Factor, Stewart A" uniqKey="Factor S" first="Stewart A" last="Factor">Stewart A. Factor</name>
<affiliation wicri:level="2"><nlm:affiliation>Emory University, Atlanta, Georgia, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Emory University, Atlanta, Georgia</wicri:regionArea>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Burke, Joshua" sort="Burke, Joshua" uniqKey="Burke J" first="Joshua" last="Burke">Joshua Burke</name>
<affiliation wicri:level="2"><nlm:affiliation>Neurocrine Biosciences, San Diego, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurocrine Biosciences, San Diego, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mandri, Daniel" sort="Mandri, Daniel" uniqKey="Mandri D" first="Daniel" last="Mandri">Daniel Mandri</name>
<affiliation wicri:level="2"><nlm:affiliation>Biscayne Bay Institute, Miami, Florida, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Biscayne Bay Institute, Miami, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Castro Gayol, Julio C" sort="Castro Gayol, Julio C" uniqKey="Castro Gayol J" first="Julio C" last="Castro-Gayol">Julio C. Castro-Gayol</name>
<affiliation wicri:level="2"><nlm:affiliation>Research in Miami, Miami, Florida, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Research in Miami, Miami, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Tardive dyskinesia is a persistent movement disorder induced by chronic neuroleptic exposure. NBI-98854 is a novel, highly selective, vesicular monoamine transporter 2 inhibitor. We present results of a randomized, 6-week, double-blind, placebo-controlled, dose-titration study evaluating the safety, tolerability, and efficacy of NBI-98854 for the treatment of tardive dyskinesia.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
<li>Floride</li>
<li>Géorgie (États-Unis)</li>
</region>
<settlement><li>Tampa</li>
</settlement>
<orgName><li>Université de Floride du Sud</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="O Brien, Christopher F" sort="O Brien, Christopher F" uniqKey="O Brien C" first="Christopher F" last="O'Brien">Christopher F. O'Brien</name>
</region>
<name sortKey="Burke, Joshua" sort="Burke, Joshua" uniqKey="Burke J" first="Joshua" last="Burke">Joshua Burke</name>
<name sortKey="Castro Gayol, Julio C" sort="Castro Gayol, Julio C" uniqKey="Castro Gayol J" first="Julio C" last="Castro-Gayol">Julio C. Castro-Gayol</name>
<name sortKey="Factor, Stewart A" sort="Factor, Stewart A" uniqKey="Factor S" first="Stewart A" last="Factor">Stewart A. Factor</name>
<name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A" last="Hauser">Robert A. Hauser</name>
<name sortKey="Jimenez, Roland" sort="Jimenez, Roland" uniqKey="Jimenez R" first="Roland" last="Jimenez">Roland Jimenez</name>
<name sortKey="Mandri, Daniel" sort="Mandri, Daniel" uniqKey="Mandri D" first="Daniel" last="Mandri">Daniel Mandri</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000155 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000155 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:26346941
   |texte=   NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26346941" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.

NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.